Ibrahim Nassour, MD, MSCS - Research

Research at a glance

Top areas of exploration

Pancreatic Neoplasms , 23 publications
Adenocarcinoma , 17 publications
Robotic Surgical Procedures , 12 publications
Pancreaticoduodenectomy , 12 publications

Research activity

92 publications

1,539 citations

Why is this important?

Active clinical trials

Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer

This phase III trial compares perioperative chemotherapy (given before and after surgery) versus adjuvant chemotherapy (given after surgery) for the treatment of pancreatic cancer that can be removed by surgery (removable/resectable). Chemotherapy鈥�

Investigator: Ibrahim Nassour
Status: Accepting Candidates
Ages: 18 Years - N/A
Sexes: All

My publications

92 publications

2022

Arid1a loss potentiates pancreatic 尾-cell regeneration through activation of EGF signaling.

Cell reports

鈥�

2022

Chemotherapy is associated with improved survival in a national cohort of stage IV pancreatic adenosquamous carcinoma.

Journal of gastrointestinal oncology

鈥�

2022

Clinical Trials in Hepatopancreatobiliary Surgery: Assessing Trial Characteristics, Early Discontinuation, Result Reporting, and Publication.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract

鈥�

2022

From bench to bedside: Pursuing equity in precision medicine approaches to pancreatic cancer care.

Frontiers in oncology

鈥�

2022

Lenvatinib inhibits the growth of gastric cancer patient-derived xenografts generated from a heterogeneous population.

Journal of translational medicine

鈥�

网红黑料